Aera Therapeutics is a startup based in the United States, most recent round Series B, 1 tracked investor.
Aera Therapeutics is a company founded in 2021 headquartered in the United States. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
Aera Therapeutics develops next-generation enabling delivery technologies and precision payloads to unlock the full potential of genetic medicines, focusing on targeted lipid nanoparticles, antibody oligonucleotide conjugates, and protein nanoparticles to treat various diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.